|
Volumn 28, Issue 4, 1999, Pages 770-777
|
Randomized, placebo-controlled trial of HA-1A, a human monoclonal antibody to endotoxin, in children with meningococcal septic shock
a a,a a a,a a a a,a a,a a a a a a a a a a a a a more.. |
Author keywords
[No Author keywords available]
|
Indexed keywords
CENTOXIN;
CORTICOSTEROID;
ANTIBODY RESPONSE;
ARTICLE;
BACTERIUM DETECTION;
CHILD;
CHILDHOOD MORTALITY;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE COURSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG HYPERSENSITIVITY;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
HUMAN;
HYPOTENSION;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
MALE;
MENINGOCOCCEMIA;
MULTICENTER STUDY;
NEISSERIA MENINGITIDIS;
ORAL DRUG ADMINISTRATION;
PASSIVE IMMUNIZATION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
|
EID: 0032928026
PISSN: 10584838
EISSN: None
Source Type: Journal
DOI: 10.1086/515184 Document Type: Article |
Times cited : (134)
|
References (27)
|